IDX Integral Diagnostics Ltd
- 3.030
- +0.030+1.00%
Integral Diagnostics Ltd News
Internal Diagnostics' Set for Upside to Returns Post Merger With Capitol Health, Jarden Says
Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
ACCC Conditionally Clears Integral Diagnostics' Proposed Acquisition of Capitol Health
Integral Expects to Complete Acquisition on December 20
Integral Diagnostics Will Divest a Capitol Radiology Clinic in Victoria State
Australian Competition Regulator Will Not Block Integral Diagnostics' Acquisition of Capitol Health
Here's the Latest Broker Upgrades on ASX All Ords Shares
Integral Diagnostics Secures Bull on Merger -- Market Talk
Integral Diagnostics Started With A$3.87/Share Target Price by Bell Potter>IDX.AU
Integral Diagnostics Started at Buy by Bell Potter >IDX.AU
Capitol Health Shareholders Vote in Favor of Proposed Merger With Integral Diagnostics
ACCC Delays Decision on Capitol Health's Divestment of Victoria Clinic
Integral Diagnostics in Talks With Competition Watchdog Over Divestment of Capitol Health's Victoria Clinic
Positive Report for Integral Diagnostics Ltd. (IDX) From Jarden
Integral Diagnostics Ltd: AGM - CEO Address and Presentation
Capital Health's Merger With Integral Diagnostics to Head to Court on Nov. 1
The Past Three Years for Integral Diagnostics (ASX:IDX) Investors Has Not Been Profitable
Integral Diagnostics Upgraded to Buy From Overweight by Jarden
Integral Diagnostics Limited's (ASX:IDX) Market Cap Touched AU$695m Last Week, Benefiting Both Retail Investors Who Own 42% as Well as Institutions
No Data